750 related articles for article (PubMed ID: 28710707)
1. Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012-2015: A Study from the Norwegian Prescription Database.
Urbaniak AM; Strøm BO; Krontveit R; Svanqvist KH
Drugs Aging; 2017 Aug; 34(8):635-645. PubMed ID: 28710707
[TBL] [Abstract][Full Text] [Related]
2. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
4. Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study.
Haastrup SB; Hellfritzsch M; Rasmussen L; Pottegård A; Grove EL
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):452-463. PubMed ID: 29664236
[TBL] [Abstract][Full Text] [Related]
5. Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults.
Fohtung RB; Novak E; Rich MW
J Am Geriatr Soc; 2017 Nov; 65(11):2405-2412. PubMed ID: 28832920
[TBL] [Abstract][Full Text] [Related]
6. Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014.
Weitz JI; Semchuk W; Turpie AG; Fisher WD; Kong C; Ciaccia A; Cairns JA
Clin Ther; 2015 Nov; 37(11):2506-2514.e4. PubMed ID: 26481493
[TBL] [Abstract][Full Text] [Related]
7. Identifying Factors That Predict the Prescription of Non-vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation.
Shurrab M; Ko DT; McElhaney J; Henderson M; Danon A; Quinn KL; O'Donnell D; Crystal E; Newman D
J Am Med Dir Assoc; 2019 Aug; 20(8):984-987. PubMed ID: 30853427
[TBL] [Abstract][Full Text] [Related]
8. Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience.
Simons LA; Ortiz M; Freedman B; Waterhouse BJ; Colquhoun D
Curr Med Res Opin; 2017 Jul; 33(7):1337-1341. PubMed ID: 28425296
[TBL] [Abstract][Full Text] [Related]
9. Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.
Zhu J; Alexander GC; Nazarian S; Segal JB; Wu AW
Pharmacotherapy; 2018 Sep; 38(9):907-920. PubMed ID: 29920705
[TBL] [Abstract][Full Text] [Related]
10. Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
Steinberg BA; Shrader P; Pieper K; Thomas L; Allen LA; Ansell J; Chan PS; Ezekowitz MD; Fonarow GC; Freeman JV; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli GV; Reiffel JA; Singer DE; Peterson ED; Piccini JP;
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29453305
[TBL] [Abstract][Full Text] [Related]
11. The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in rural Australia.
Bellinge JW; Paul JJ; Walsh LS; Garg L; Watts GF; Schultz C
Med J Aust; 2018 Jan; 208(1):18-23. PubMed ID: 29320668
[TBL] [Abstract][Full Text] [Related]
12. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
[TBL] [Abstract][Full Text] [Related]
13. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
Lee SI; Sayers M; Lip GY; Lane DA
Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
[TBL] [Abstract][Full Text] [Related]
14. Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience.
Simons LA; Ortiz M; Freedman SB; Waterhouse BJ; Colquhoun D; Thomas G
Curr Med Res Opin; 2016 Nov; 32(11):1857-1861. PubMed ID: 27463735
[TBL] [Abstract][Full Text] [Related]
15. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
Martinez C; Katholing A; Wallenhorst C; Freedman SB
Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
[TBL] [Abstract][Full Text] [Related]
16. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
Shiyovich A; Shalev V; Chodick G; Tirosh M; Katz A; Klar MM; Shuvy M; Pereg D; Minha S
BMC Cardiovasc Disord; 2021 Oct; 21(1):493. PubMed ID: 34645389
[TBL] [Abstract][Full Text] [Related]
17. Prescribing Trends of Oral Anticoagulants from 2010 to 2020 in Shanghai, China: A Retrospective Study.
Zhang C; Wang J; Yang Y; Ma EL; Lin HW; Liu BL; Gu ZC
Clin Appl Thromb Hemost; 2022; 28():10760296221132551. PubMed ID: 36250531
[TBL] [Abstract][Full Text] [Related]
18. Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation.
Park S; Je NK
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):656-664. PubMed ID: 34558337
[TBL] [Abstract][Full Text] [Related]
19. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
Eek AK; Øie E; Granas AG
Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
[TBL] [Abstract][Full Text] [Related]
20. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
